tirzepatide and hormone replacement therapy FDA approval for Zepbound (tirzepatide) injection, the first only obesity treatment of its kind that activates both GIP and GLP-1 receptors - Eli Lilly Body weight reduction in women

Semaglutide 2.4 mg reduced the rate of major adverse cardiovascular events (MACE: cardiovascular death, nonfatal myocardial infarction, nonfatal stroke) by 20% compared to placebo (HR 0.80

Non-Gastrointestinal Side Effects and How Long They Last Fatigue, headache, and dizziness occur in 1015% of semaglutide users, primarily during the first two weeks after starting or increasing dose

Today, however, it is a reality

Side effects may include nausea, vomiting and diarrhea

It also showed an increase in insulin resistance

The bottom line is to consult a healthcare professional immediately if you experience worsening gastrointestinal side effects or develop signs of low blood sugar after switching from Ozempic to Mounjaro